Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Journal of Long-Term Effects of Medical Implants
SJR: 0.145 SNIP: 0.491 CiteScore™: 0.89

ISSN Imprimir: 1050-6934
ISSN En Línea: 1940-4379

Journal of Long-Term Effects of Medical Implants

DOI: 10.1615/JLongTermEffMedImplants.2014010493
pages 219-224

Management Strategies for Total Hip Arthroplasty in Sickle Cell Patients

Yashika D. Patel
Seton Hall University, School of Health and Medical Sciences, Department of Orthopaedic Surgery, South Orange Village, NJ
Bartlomiej W. Szczech
Seton Hall University, School of Health and Medical Sciences, Department of Orthopaedic Surgery, South Orange Village, NJ
Sujal Patel
Seton Hall University, School of Health and Medical Sciences, Department of Orthopaedic Surgery, South Orange Village, NJ
Kimona Issa
School of Health and Medical Sciences, Department of Orthopaedics, Seton Hall University, 400 S Orange Ave, South Orange, New Jersey
Bhaveen V. Kapadia
Department of Orthopaedic Surgery and Rehabilitation Medicine, SUNY Downstate Medical Center/University Hospital Brooklyn, Brooklyn, NY
Michael A. Mont
Center for Joint Preservation and Replacement, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland

SINOPSIS

Sickle cell anemia is an inherited hemoglobinopathy in which there is a structural change to the erythrocyte from round to crescent shaped or sickled. These abnormally shaped cells can block small vessels resulting in compromise of vascular supply, pain, and end-organ damage. These patients are particularly susceptible to hip osteonecrosis, which in late stages may require a total hip arthroplasty. Historically, total hip arthroplasty had inferior outcomes in this patient population due to poorer clinical outcomes and higher perioperative complications. During recent decades, however, there have been some improvements in the medical management of these patients, which has potentially improved the clinical outcomes of this procedure. In this article, we review all reported management strategies for the perioperative care of sickle cell anemia patients undergoing total hip arthroplasty.


Articles with similar content:

Long-Term Complications of Mesh Repairs for Abdominal-Wall Hernias
Journal of Long-Term Effects of Medical Implants, Vol.21, 2011, issue 3
Duray Seker, Hakan Kulacoglu
Temporomandibular Joint Disorders: Artificial Joint Replacements and Future Research Needs
Journal of Long-Term Effects of Medical Implants, Vol.16, 2006, issue 6
Ajay Kashi, Robert W. Christensen
Large Diameter Total Hip Replacement for Acute Displaced Femoral Neck Fracture
Journal of Long-Term Effects of Medical Implants, Vol.29, 2019, issue 1
James Pritchett
Advances in Biomaterials for the Treatment of Intervertebral Disc Degeneration
Journal of Long-Term Effects of Medical Implants, Vol.22, 2012, issue 1
Michele Marcolongo, Yakira Kirzner, Sujata K. Bhatia
Patellofemoral Stress Syndrome
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.7, 1995, issue 4
Karen LaBrier, Daniel B. O'Neill